Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

The aim of this study was to investigate whether the enumeration of circulating tumor cells (CTCs) in blood can differentiate between true localized and metastatic prostate cancer. A cross-sectional study of 104 prostate cancer patients with newly diagnosed high-risk prostate cancer was conducted. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieślikowski, Wojciech A., Budna-Tukan, Joanna, Świerczewska, Monika, Ida, Agnieszka, Hrab, Michał, Jankowiak, Agnieszka, Mazel, Martine, Nowicki, Michał, Milecki, Piotr, Pantel, Klaus, Alix-Panabières, Catherine, Zabel, Maciej, Antczak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017349/
https://www.ncbi.nlm.nih.gov/pubmed/31936460
http://dx.doi.org/10.3390/cancers12010160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017349/
https://www.ncbi.nlm.nih.gov/pubmed/31936460
http://dx.doi.org/10.3390/cancers12010160

Ejemplares similares